Skip to main content

PICASSO24 Awards

NASA has made four new awards through the Planetary Instrument Concepts for the Advancement of Solar System Observations (PICASSO) program. The PICASSO portfolio focuses on early-stage ideas — defined as concepts at a Technology Readiness Level (TRL) of 1 to 3 on a nine-point scale — that would support the development of instrument hardware which […] The post PICASSO24 Awards appeared first on…

science.nasa.gov ·6h ago

PICASSO24 Awards

We haven't written up this one. NASA Science has the full story — the link below goes straight to it.

Read the original at science.nasa.gov →

More in Science

NASA’s 2024 DALI Award Selections

The DALI24 projects will expand NASA’s portfolio of technology available for the development of instruments for use in future lunar missions, including the agency’s Commercial Lunar Payload Services…

6h ago ·science.nasa.gov

Young Chimps Develop Their Own Accents, New Study Finds

Researchers tracking grunts, whimpers and laughter across two geographically separated chimpanzee populations found that vocal differences sharpen with age.

6h ago ·sci.news

'Soft crosslinking' strategy makes brittle, glassy plastics tougher

Glassy polymers are those whose chains become immobilized below their glass transition temperature. The immobilized chains make them hard and stiff but also brittle, causing them to fracture when…

6h ago ·phys.org

NASA PICASSO Awards

NASA has made 10 new awards through the Planetary Instrument Concepts for the Advancement of Solar System Observations (PICASSO) program.

6h ago ·science.nasa.gov

U.N. approves resolution in support of map that shows Africa’s true size

16th-century Mercator map diminishes size of Africa; Togo-led U.N. initiative to further African Union campaign for new map; West African nation aims to use Equal Earth map in schools by the end of…

5h ago ·thehindu.com

CRISPR gene-editing therapy safely and continuously lowers cholesterol and triglycerides, first-in-human trial shows

A Cleveland Clinic first-in-human clinical trial has shown that a one-time infusion of a gene-editing therapy using CRISPR-Cas9 was effective and safe in reducing LDL ("bad") cholesterol and…

5h ago ·medicalxpress.com

More from Friday 4 September →